Our study suggests expression of ERCC1 and BRCA1 mRNA could be helpful in predicting the clinical outcome of NSCLC and understand the pathogenesis of chemotherapy for NSCLC. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.